SWAV

News

globenewswire.comRubicon Point Partners Acquires Shockwave Medical Headquarters Campus in Santa Clara, Californiaglobenewswire.comMay 14

Trade SWAV

About ShockWave Medical, Inc.

ShockWave Medical, Inc. is a medical technology firm that specializes in the development and global commercialization of intravascular lithotripsy (IVL) systems. This innovative approach is designed to treat calcified plaque in individuals affected by peripheral vascular, coronary vascular, and heart valve conditions. The company's product offerings include the M5 catheter for addressing above-the-knee peripheral artery disease, the C2 catheter specifically for coronary artery disease, and the S4 catheter, which targets below-the-knee peripheral artery disease. ShockWave Medical serves a professional clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists, leveraging both direct sales teams and distribution partners. The organization was founded in 2009 and is based in Santa Clara, California.

CEO: Douglas E. Godshall
IPO Date: Mar 7, 2019

Market Data

Open: $334.85
High: $334.90
Low: $334.75
Volume: 3.9M
Avg Volume: 1.3M
52W High: $334.90
52W Low: $157.00

Valuation

Market Cap: $12.6B
Enterprise Value: $13B
Dividend Yield: 0.00%

Financials

Free Cash Flow: $165.5M
Revenue: $730.2M
Net Income: $147.3M
Cash: $328.4M
Debt: $770.6M

Events

EarningsMay 6

EPS est. 0.98 · actual 1.44